Beat The Denominator

Consider Oscar Health (OSCR) as a medium-term investment, with a potential January catalyst from an ACA subsidy vote and a price target of $40 to $50. For a core long-term holding, Hims & Hers (HIMS) is presented as a high-conviction play on the future of healthcare, set to capture customers priced out of traditional insurance. Coinbase (COIN) is another key opportunity, as its expansion into stock trading and derivatives could transform it into a comprehensive financial platform. In cryptocurrency, Solana (SOL) is viewed as a strong buy on any weakness, with a potential price floor noted around the $118 level. Lastly, watch for a potential short-term dip in Bitcoin (BTC) to the $82,000 level as a possible entry point.

MicroStrategy (MSTR) is developing a new Bitcoin-backed stablecoin designed to have zero volatility and offer a yield of 6-8%. This product aims to attract conservative investors by targeting the multi-trillion dollar bank deposit market, representing a massive potential revenue stream for the company. The company's recent aggressive capital raises are likely a strategic move to accumulate Bitcoin (BTC) as collateral for this future offering. CEO Michael Saylor is actively pursuing a partnership with a major bank like JPMorgan (JPM) or Morgan Stanley (MS) to launch and validate the product. A successful launch would transform MSTR from a passive BTC holder into an active financial innovator, creating a significant long-term bullish catalyst.

Consider buying Hims & Hers Health (HIMS), which is viewed as extremely cheap following a price drop despite positive news like significant insider buying. Bitcoin miners pivoting to AI and HPC services, such as CleanSpark (CLSK), Cipher Mining (CIFR), and Hut 8 (HUT), present a key opportunity as the market ignores their major new deals. The Yandex spin-off Nebius is highlighted as a deeply undervalued company with guided 10x-20x revenue growth and valuable hidden assets like its autonomous vehicle division, AVRide. For investors holding Bitcoin (BTC), a minimum holding period of four years is recommended to navigate market volatility. It is advised to avoid rotating into overpriced defensive stocks like Philip Morris (PM), which are seen as fundamentally weaker investments.

MicroStrategy (MSTR) is showing relative strength against Bitcoin and could see a major catalyst from a potential new financial product following meetings with JP Morgan and Morgan Stanley. The irrational sell-off in innovation stocks may present buying opportunities for long-term investors. For example, consider Hims & Hers Health (HIMS), which recently dropped despite significant insider buying. Another potential opportunity is KULR Technology Group (KULR), which reversed sharply lower despite positive partnership news. Finally, watch for a potential hyperscaler partnership announcement from crypto miner CleanSpark (CLSK), which could be a significant catalyst for the stock.

Sezzle (SEZL) is presented as the top pick in the Buy Now, Pay Later space, offering a compelling combination of rapid growth and a valuation roughly 60% below its prior highs. The second-highest conviction idea is Remitly (RELY), a remittance company considered the cheapest stock in the analysis with a clear path to improving profitability. Conversely, investors are advised to avoid legacy payment giants Visa (V) and Mastercard (MA) due to their extremely high valuations and significant long-term disruption risk. Similarly, mature fintechs like PayPal (PYPL) and Block (SQ) are considered unattractive as their growth has slowed significantly. The core strategy is to favor fast-growing, cheaply valued disruptors over slow-growing, expensive incumbents.

MicroStrategy (MSTR) is presented as a significant buying opportunity, currently seen as severely undervalued for investors who are bullish on Bitcoin. The core investment thesis relies on the long-term appreciation of Bitcoin (BTC) as a store of value against currency devaluation. While Tesla (TSLA) is a core holding, its recent all-time high price makes it a less attractive entry point than MSTR right now. For a long-term growth theme, consider researching Hims & Hers Health (HIMS) as a key disruptor in the telehealth and pharmacy space. Investors are advised to avoid companies vulnerable to technological disruption, such as legacy automakers and retail pharmacies like CVS.

NVIDIA (NVDA) is presented as the top AI investment, considered undervalued on a growth-adjusted basis compared to competitors like AMD. For a key infrastructure play, Supermicro (SMCI) is highlighted as a "dirt cheap" liquid cooling specialist essential for next-gen AI chips and is currently in a lower trading range. For investors with a high risk tolerance, Nebius (NBIS) is the favorite small-cap pick, projected to grow revenue 10-20x by 2026. A more conservative "picks and shovels" alternative is Taiwan Semiconductor (TSMC), the monopoly manufacturer for the entire industry. In contrast, investors should be cautious about chasing recent performers like Micron (MU) at current prices.

Consider investing in high-growth companies whose stocks have been unfairly punished despite strong business performance. Digital health platform Hims & Hers (HIMS) is presented as a top opportunity, growing at 47% year-over-year while trading at what is described as a "stupid cheap" valuation. In the crypto sector, CleanSpark (CLSK) is highlighted as a deeply undervalued Bitcoin miner, trading at just 2.3x its projected 2025 adjusted earnings when accounting for its Bitcoin holdings. CLSK also has a potential catalyst from its expansion into AI computing, which the market is currently ignoring. Finally, fintech disruptor SoFi (SOFI) is another name to watch, with growth expected to accelerate and benefit from brand visibility during the upcoming World Cup.

Consider NVIDIA (NVDA) as a potential buying opportunity, as its recent stock price decline appears disconnected from its outstanding earnings report. For leveraged exposure to Bitcoin, view MicroStrategy (MSTR) as a long-term holding that continuously issues stock to accumulate more BTC. Strategic entry points for Bitcoin (BTC) may appear during potential price drops observed on Sunday nights and Monday mornings. Exercise caution as the broader market is in a strong risk-off mode, heavily selling assets like AI, small caps, and crypto-related stocks. This widespread selling could present value opportunities in fundamentally strong companies for investors with a long-term perspective.

Consider a long-term hold of MicroStrategy (MSTR) common stock, as the company remains committed to its Bitcoin accumulation strategy and is secure in the NASDAQ 100. A key upcoming catalyst is a MicroStrategy debt instrument, potentially ticker STRC, which is expected to reach a price of 100 soon. This event is predicted to trigger a massive influx of capital for new Bitcoin purchases, reinforcing the long-term bullish case for BTC. Investors are strongly advised to avoid trading complex options or leveraged products on these volatile assets due to extreme timing risk. The primary strategy is to remain patient and hold core positions through this "boring" market phase.

Hims & Hers (HIMS) is presented as a high-conviction buying opportunity, viewed as a "steal" in the digital health sector due to its strong performance and low stock price. For a deep-value play, consider CoreMedics (CRMD), an anti-infection company with projected 120% revenue growth that is described as "super special" cheap. Despite its large size, NVIDIA (NVDA) is considered undervalued on a growth-adjusted basis, making its recent pullback a potential entry point. The Real Brokerage (REAX) offers a high-growth investment in the real estate sector, seen as "ridiculously cheap" relative to its massive revenue projections. For a short-term trade, Oscar Health (OSCR) is highlighted as a "swing trade" opportunity based on its extremely low valuation and near-term catalysts.

For investors bullish on Bitcoin, consider MicroStrategy (MSTR) as the established industry leader over newer, less clear competitors like 21 Capital (XXI). The most compelling opportunity may be MSTR's Strike preferred instrument, which offers a 9.1% quarterly dividend. This instrument includes a unique perpetual stock option, providing significant upside potential without the time decay of traditional options. Specifically, this feature allows the conversion of 10 Strike shares into 1 MSTR share if MSTR stock reaches $1,000. While Bitcoin itself remains a volatile long-term hold, MSTR's Strike offers a structured way to gain exposure with an income component.